Clarithromycin film-coated tablets are indicated in adults and adolescents 12 years and older for the treatment of the following bacterial infections, when caused by clarithromycin-susceptible bacteria (see section 4.4 and 5.1). Diltiazem is used alone or together with other medicines to treat angina (severe chest pain) or hypertension (high blood pressure). High blood pressure adds to the workload of the heart and arteries. What is cefdinir used for? This prescription antibiotic is used to treat common bacterial infections, such as bronchitis, middle ear infection, and sinus infection. Amoxicillin is a prescription antibiotic which is used to treat a wide variety of bacterial infections. Learn about side effects, drug interactions, dosages, warnings, and more. Unfortunately our full catalog may not be displayed in your state. If you contact our Customer Support by one of the methods below, we will be able to assist you in locating the product you are looking for. Use of any antimicrobial therapy, such as clarithromycin, to treat H. pylori infection may select for drug-resistant organisms. The physician should not prescribe clarithromycin to pregnant women without carefully weighing the benefits against risk, particularly during the first three months of pregnancy (see section 4.6). Clarithromycin is the generic form of the brand-name prescription drug Biaxin, an antibiotic used to treat bacterial infections. Clarithromycin is often used for pneumonia, bronchitis, and. INTRODUCTION. Multiple antibiotic regimens have been evaluated for Helicobacter pylori therapy. However, few regimens have consistently achieved high eradication rates. Amoxicillin is an antibiotic in the penicillin group of drugs. Amoxicillin is used to treat many different types of infections caused by bacteria, such as ear infections, bladder infections, pneumonia, gonorrhea, and E. coli or salmonella infection. 250 mg PO every 12 hours for 7 to 14 days. Clinical practice guidelines recommend clarithromycin as a monotherapy option in previously healthy outpatients with no risk factors for drug-resistant S. pneumoniae and without therapy in the preceding 3 months.